Chronic inflammation, a silent yet powerful force, lurks beneath the surface of HIV management, even in those who achieve viral suppression. This phenomenon, dubbed "inflammaging" by Irini Sereti, M.D., Ph.D., is a growing concern for healthcare professionals caring for people living with HIV. It's not just about the virus anymore; it's about the complex interplay of inflammation, aging, and overall health.
In a recent interview at the Conference on Retroviruses and Opportunistic Infections (CROI 2026), Sereti, a renowned expert in HIV pathogenesis, delves into the mechanisms driving this insidious process. She argues that metabolism, often overlooked, emerges as a crucial therapeutic target in combating inflammaging.
Unraveling the Inflammaging Mystery
Sereti's research focuses on the intricate dance of inflammatory complications in HIV-positive individuals. Her work highlights the role of inflammasomes, the intricate microbiome, genetic factors, and immune senescence as key players in this inflammatory symphony.
But what's truly fascinating is how these elements converge to create a perfect storm of chronic inflammation. It's not just about the virus anymore; it's about the body's own inflammatory responses and how they contribute to accelerated aging.
The Metabolic Connection
Here's where metabolism comes into play. Sereti's interview emphasizes that metabolic dysfunction is intricately linked to inflammaging. By targeting metabolic pathways, we might be able to mitigate the inflammatory cascade and its detrimental effects on long-term health.
This is a paradigm shift in HIV care. Instead of solely focusing on viral suppression, we must consider the broader metabolic landscape and its impact on overall well-being.
A Call for Comprehensive Care
The implications of this research are profound. It challenges us to move beyond a narrow view of HIV management and embrace a holistic approach. By addressing metabolic factors alongside viral suppression, we may be able to improve quality of life and potentially slow down the aging process for people living with HIV.
However, this journey is not without its challenges. Implementing metabolic interventions alongside antiretroviral therapy requires careful consideration and further research. The complexity of the human metabolism demands a nuanced approach.
In my opinion, the future of HIV care lies in this interdisciplinary approach. By integrating metabolic insights with traditional HIV management, we can offer our patients a more comprehensive and effective treatment strategy.
As we continue to unravel the mysteries of inflammaging, one thing becomes clear: the key to successful HIV management lies in understanding and addressing the intricate relationship between inflammation, metabolism, and aging.
